Download full-text PDF

Source
http://dx.doi.org/10.1053/j.ajkd.2012.08.010DOI Listing

Publication Analysis

Top Keywords

decade kdoqi
4
kdoqi ckd
4
ckd guidelines
4
guidelines perspective
4
perspective egypt
4
decade
1
ckd
1
guidelines
1
perspective
1
egypt
1

Similar Publications

Article Synopsis
  • * The review discusses barriers and facilitators to CKD detection and management since the KDOQI classification was introduced, calling for a revised strategy aligned with the upcoming KDIGO 2024 clinical guidelines.
  • * Effective CKD care is supported by classification systems, evidence-based treatments, and policy changes, while facing challenges like clinician concerns about overdiagnosis, inadequate financial incentives, complexity in guidelines, and disruptions caused by the COVID-19 pandemic.
View Article and Find Full Text PDF

Over the last 2 decades, there has been a great accumulation of new evidence regarding the management of nutritional and metabolic aspects of kidney disease. The 2020 update to the KDOQI Clinical Practice Guideline for Nutrition in CKD provides a comprehensive up-to-date information on the understanding and care of patients with CKD. It provides updated information on nutritional aspects of kidney disease for the practicing clinician and allied health-care workers.

View Article and Find Full Text PDF

The first KDIGO (Kidney Disease: Improving Global Outcomes) guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C virus (HCV) infection was published in 2008. The ensuing decade bore witness to remarkable advances in the treatment of HCV infection following the approval of direct-acting antiviral (DAA) agents that deliver cure rates routinely >95%. In this context, the KDIGO organization correctly recognized the need for an updated HCV guideline that would be relevant to the treatment of HCV-infected patients with kidney disease in the DAA era.

View Article and Find Full Text PDF

Living kidney donation is widely practiced throughout the world. During the past 2 decades, various groups have provided guidance about the evaluation and care of living donors. However, during this time, our knowledge in the field has advanced substantially and many agreed on the need for a comprehensive, unifying document.

View Article and Find Full Text PDF

Hypertension is a modifiable risk factor for cardiovascular morbidity and mortality and reduction of elevated blood pressure (BP) remains an important intervention for slowing kidney disease progression. Over the past decade, the most appropriate BP target for initiation and titration of BP-lowering medications has been an area of intense research and debate within the clinical community. In 2017, the American College of Cardiology and the American Heart Association (ACC/AHA) in conjunction with several other professional societies released new hypertension guidelines based on data from a systematic review of clinical trials and observational data.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!